Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas ...

BKV Corporation plans to raise $300 million in a U.S. IPO. Read more on whether investors should consider this energy player.

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

BKV Corp. priced its common shares at $18 each after and will begin trading on Sept. 26, about two years after the Denver ...

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.

BKV Corporation BKV IPO will take place September, 26 on the NYSE exchange under the ticker BKV. The company is offering shares at an expected price between $19.00 and $21.00 per share with an insider ...

The U.S. IPO market has bounced back strongly in 2024 after a nearly two-year dry spell, driven by receding recession fears ...

Initial public offerings from two separate energy companies moved into the stock debut pipeline on Monday as the U.S. new ...

BKV Corp. has positioned itself as an LNG supplier near Gulf Coast markets with production averaging 718 MMcfe/d across about ...

BKV will offer 15 million shares priced between $19 and $21 each, the company said, aiming for a valuation of up to $1.77 billion in the IPO, according to its amended filing on Monday. Rate cut ...